ArticleJournal of cancer research and clinical oncology2023

Repurposing of triamterene as a histone deacetylase inhibitor to overcome cisplatin resistance in lung cancer treatment.

Kenneth K W To et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.